Otocephaly

From WikiMD's WELLNESSPEDIA

Otocephaly is a rare and lethal congenital disorder characterized by the absence or underdevelopment of the lower jaw (mandible), the absence of the ear structures (auricles), and the fusion of the upper parts of the skull (synotia). This condition is also known as agnathia-otocephaly complex.

Etiology[edit]

The exact cause of otocephaly is unknown. However, it is believed to be due to a combination of genetic and environmental factors. Some studies suggest that mutations in the PITX1 and OTX2 genes may be associated with the condition. These genes are involved in the development of the head and face. Environmental factors such as maternal diabetes, exposure to certain medications during pregnancy, and maternal alcohol consumption may also increase the risk of otocephaly.

Clinical Features[edit]

The main clinical features of otocephaly include:

  • Absence or underdevelopment of the lower jaw (agnathia)
  • Absence of the ear structures (auricularia)
  • Fusion of the upper parts of the skull (synotia)
  • Other abnormalities may include cleft palate, microstomia (small mouth), and microglossia (small tongue)

Diagnosis[edit]

Otocephaly can be diagnosed prenatally through ultrasound examination. The condition can also be confirmed after birth through physical examination and imaging studies such as computed tomography (CT) scan or magnetic resonance imaging (MRI).

Prognosis[edit]

Otocephaly is a lethal condition. Most affected infants die before birth or shortly after birth due to respiratory failure.

Management[edit]

There is currently no cure for otocephaly. Management is supportive and focuses on addressing the symptoms and complications of the condition.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.